Clinical trial
Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients
NCT00084253 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00084253 |
|---|---|
| Title | Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients |
| Official title | Phase IV Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Atazanavir/ Stavidine / Lamivudine, Atazanavir-Ritonavir/ Stavidine / Lamivudine |
| Enrollment | 200 |
| Start date | Jun 1, 2004 |
| Primary completion | Aug 1, 2006 |
| First posted | Jun 11, 2004 |
| Last update posted | Mar 5, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: